Plasma matrix metalloproteinase-7 (MMP7) (10–12) and γ-glutamyl transpeptidase (GGT) (13–16) have been suggested as promising tools in the diagnosis of BA; however, these studies have limitations such as different quantitation methods and different cut-off values were used. This evidence concerns the gene MMP7 and breast angiosarcoma.